✦ LIBER ✦

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

✍ Scribed by Press, M. F.; Finn, R. S.; Cameron, D.; Di Leo, A.; Geyer, C. E.; Villalobos, I. E.; Santiago, A.; Guzman, R.; Gasparyan, A.; Ma, Y.; Danenberg, K.; Martin, A. M.; Williams, L.; Oliva, C.; Stein, S.; Gagnon, R.; Arbushites, M.; Koehler, M. T.

Book ID: 125525872
Publisher: American Association for Cancer Research
Year: 2008
Tongue: English
Weight: 570 KB
Volume: 14
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-08-1056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor gene co

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

✍ Fabi, Alessandra; Merola, Roberta; Ferretti, Gianluigi; Di Benedetto, Anna; Anto 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 428 KB

Serum epidermal growth factor receptor a

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

✍ Kristjan S Asgeirsson, Amit Agrawal, Claire Allen, Anthony Hitch… 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 470 KB

EGFR gene amplification in breast cancer

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

✍ Bhargava, Rohit; Gerald, William L; Li, Allan R; Pan, Qiulu; Lal, Priti; Ladanyi 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 258 KB

Serum epidermal growth factor receptor/H

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer

✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a

Growth factor receptor 1 and 2 (HER1 and

Growth factor receptor 1 and 2 (HER1 and HER2) gene and protein assessment and evaluation of lapatinib plasma concentrations (PCs) in breast cancer patients

✍ Radek Trojanec; Magdalena Cizkova; Katerina Bouchalova; David Friedecky; Adriana 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Human epidermal growth factor receptor 2

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

✍ Allan Lipton; Kim Leitzel; Suhail M. Ali; Walter Carney; Greg Platek; Klaudia St 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB